Skip to main content
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
80.28
+3.39 (4.41%)
At close: Nov 13, 2026, 4:00 PM EST
81.22
+0.94 (1.17%)
After-hours: Nov 13, 2026, 7:30 PM EST

Tarsus Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-702.23-66.42-115.55-135.89-62.09-13.83
Depreciation & Amortization
2.911.821.230.880.330.31
Other Amortization
0.650.590.480.390.31-
Loss (Gain) From Sale of Assets
0.18----0.07
Loss (Gain) From Sale of Investments
-5.79-5.48-3.62-3.42-1.050.59
Stock-Based Compensation
66.7941.7227.8219.8313.468.46
Other Operating Activities
5.140.682.780.420.976.78
Change in Accounts Receivable
-27.82-38.3-30.14-16.62--
Change in Inventory
-1.32-1.75-2.05-3.11--
Change in Accounts Payable
29.766.912.544.540.823.88
Change in Other Net Operating Assets
49.4447.7833.4915.5-1.77-2.51
Operating Cash Flow
49.9-12.45-83.03-117.49-49.033.75
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-17.46-9.86-1.57-1.5-0.51-0.59
Sale (Purchase) of Intangibles
---5-4--
Investment in Securities
116.94-32.26-192.63146.11-144.12-
Investing Cash Flow
-160.9-42.12-199.2140.6-144.63-0.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--751020-
Net Debt Issued (Repaid)
--751020-
Issuance of Common Stock
127.44143.39105.69120.1874.940.32
Other Financing Activities
7.19--26.04--0.95-0.3
Financing Cash Flow
134.63143.39154.66130.1893.990.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
23.6388.82-127.57153.29-99.673.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
32.44-22.31-84.59-119-49.543.16
Free Cash Flow Growth
------
Free Cash Flow Margin
4.75%-4.94%-46.24%-682.04%-191.88%5.54%
Free Cash Flow Per Share
0.74-0.53-2.25-4.05-2.010.15
Levered Free Cash Flow
79.94-0.16-50.48-74.49-27.354.74
Unlevered Free Cash Flow
84.714.83-46.05-72.78-26.294.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
8.038.347.662.881.68-
Change in Working Capital
50.0714.643.840.31-0.951.37
SEC Filings: 10-K · 10-Q